Skip to main content

FULL MENU Close Menu

Diseases & Conditions
MD-IQ
RA
Business of Medicine
Coronavirus Updates

Conference Coverage

Guselkumab achieves highest-ever response rates in psoriasis

Publish date: October 12, 2016

bjancin@frontlinemedcom.com

Pages

« first
1
2

Next Article:

Birth outcomes unaffected by paternal immunosuppressive therapy

Psoriatic Arthritis

This Publication

About Us
Advertise
Contact Us
Corporate Management
Customer Service
Editorial Advisory Board
Editorial Staff
Subscribe to Rheumatology News

Facebook
Twitter

Specialty Focus

Psoriatic Arthritis
Spondyloarthropathies
Rheumatoid Arthritis
Osteoarthritis

Top Sections

Commentary

Editorial Policy

Medscape Customer Support

Frequently Asked Questions

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close

MDedge Home
Diseases & Conditions
Subspecialties
- Pediatrics
Business of Medicine
Diversity in Medicine

Explore

20th Anniversary
Challenge Center
Explore
- Psoriatic Arthritis Challenge Center
CME
Condition Center
Explore
- Psoriatic Arthritis Resource Center
Conference ReCAP
For Residents
Latest News
Explore
Multimedia
Explore
- Audio
  Explore
- Video
Perspectives
Explore
Quizzes & Polls
Explore
- MD-IQ
ReCAP
Research Summaries
Explore
- Clinical Edge Journal Scan
Roundtables
Sponsored Content
Explore
Subscribe to Rheumatology News
Supplements

Medical Directors / Pharmacy Directors
Nurse Practitioners / Physician Assistants
Residents
VA / DoD / PHS

More

MDedge